This article discusses the DOJ’s growing crackdown on healthcare fraud, focusing on illegal speaker programs like Gilead’s $202 million settlement. It stresses the importance of strong compliance, ...

WASHINGTON — Even before he took over the Food and Drug Administration, Marty Makary called for frequent, transparent meetings of the independent panels that advise the agency on ...

FDA chief’s goals of ‘radical transparency’ threatened by agency cuts Layoffs will make it harder to keep advisory committee meetings strong and independent, according to staff and ethics ...

PALM SPRINGS, Calif. (KESQ) The U.S. Food and Drug Administration has approved a groundbreaking HIV prevention shot that only needs to be taken twice a year. Medical experts are calling it one of ...

The biopharmaceutical company said Friday that the U.S. Food and Drug Administration has extended the review period by three months to Sept. 19, giving it more time to review additional chemistry ...

From AI-powered inspections to bold regulatory shifts on dyes and sugar, the FDA has made waves in 2025. Here are the 17 most impactful stories shaping the future of food regulation.

SAN DIEGO, Calif. (KESQ)- This past Monday, U.S. Border Patrol agents and Homeland Security discovered the origin point of a sophisticated drug smuggling tunnel connecting Tijuana to the San Diego ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health.

Supporters have praised Musk’s transparency and viewed the negative results as vindication against what they characterize as unfounded allegations designed to damage his reputation.

Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.